Rheumatoid arthritis: The predictable effect of small immune complexes in which antibody is also antigen

British Journal of Rheumatology

Volumn 37, Issue 2, 1998, Pages 126-130

  Edwards, J C W ^a,b   Cambridge, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Rheumatology Unit   (United Kingdom)

Author keywords

B lymphocyte; CD16; Immune complexes; Macrophage; Rheumatoid factor; Synovium

Indexed keywords

AUTOANTIBODY; COMPLEMENT RECEPTOR; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; DEGRADATION; ENDOTHELIUM; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HYPOTHESIS; LYMPHOID TISSUE; MACROPHAGE; MACROPHAGE ACTIVATION; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0031903045     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.2.126     Document Type: Review

References (39)

1. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 1940;17: 172-88.
2. Rose HM, Ragan C, Pearce E, Lipman MO. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 1948;68:1-6.
3. Youinou PY, Morrow JW, Lettin AWF, Lydyard PM, Roitt IM. Specificity of plasma cells in the rheumatoid synovium I. Scand J Immunol 1984;20:307-15.
4. Mannik M, Nardella FA. IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis 1985;11:551-72.
5. Thompson KM, Borretzen M, Natvig JB. New data on rheumatoid factors in health and disease. Rheumatol Eur 1995;24(suppl. 2):165-7.
6. Børretzen M, Randen I, Natvig JB, Thompson KM. Structural restriction in the heavy chain CDR3 of human rheumatoid factors. J Immunol 1995;155:3630-7.
7. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Biji H et al. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 1994; 344:1125-7.
8. Nardella FA, Dayer JM, Roelke M, Krane SM, Mannik M. Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells. Rheumatol Int 1983;3:183-5.
9. Lydyard PM, Fanger MW. Characteristics and function of Fc receptors on human lymphocytes. Immunology 1982;47:1-17.
10. van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity. Immunol Today 1993;14:215-21.
11. Huizinga TW, Roos D, von dem Borne AE. Fc-gamma receptors: mediators, targets and markers of disease. Baillière's Clin Haematol 1991;4:889-902.
12. Edwards JCW, Leigh RD, Cambridge G. Expression of molecules involved in B lymphocyte survival and proliferation by synovial fibroblasts. Clin Exp Immunol 1997;108:407-14.
13. Edwards JCW, Blades S, Cambridge G. Restricted expression of FcyRIII in synovium and dermis; implications for tissue targeting in rheumatoid arthritis. Clin Exp Immunol 1997;108:401-6.
14. Davies KA. Complement, immune complexes and systemic lupus erythematosus. Br J Rheumatol 1996; 35:5-23.
15. Brown PB, Nardella FA, Mannik M. Human complement activation by self-associated IgG rheumatoid factors. Arthritis Rheum 1982;25:1101-7.
16. Hendrich C, Kuipers JG, Kolanus W, Hammer M, Schmidt RE. Activation of CD16+ effector cells by rheumatoid factor complex. Arthritis Rheum 1991;34: 423-31.
17. Bordessoule D, Jones M, Gatter KC, Mason DY. Immunohistological patterns of myeloid antigens. Br J Haematol 1993;83:370-83.
18. Tuijnman WB, Van Wichen DF, Schuurman HJ. Tissue distribution of human IgG Fc receptors CD16, CD32 & CD64: an immuno-histochemical study. Acta Pathol Microbiol Immunol Scand 1993;101:319-29.
19. Wong HL, Welch GR, Brandes ME, Wahl SM. IL-4 antagonizes induction of Fc gamma RIII (CD16) expression by transforming growth factor-beta on human monocytes. J Immunol 1991;147:1843-8.
20. Klein Nulend J, Roelofsen J, Sterck JG et al. Mechanical loading stimulates the release of TGFβ activity by cultured mouse calvariae and periosteal cells. J Cell Physiol 1995;163:115-9.
21. Maini RN, Zvaifler N. Rheumatoid arthritis. In: Klippel J, Dieppe P, eds. Rheumatology. St Louis: Mosby, 1994:3.1.1-15.6.
22. Marsh CB, Wewers MD, Tan LC, Rovin BH. Fcγ receptor cross-linking induces peripheral blood mononuclear cell monocyte chemo-attractant protein-1 expression. J Immunol 1997;158:1078-84.
23. Palmer DG. The anatomy of the rheumatoid lesion. Br Med Bull 1995;51:286-95.
24. Hoshino S, Oshimi K, Teramura M, Mizoguchi H. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with lymphocyte proliferative disorders. Blood 1991;78:3232-40.
25. Barton JC, Prasthofer EF, Egan ML. Rheumatoid arthritis associated with expanded populations of granular lymphocytes. Ann Intern Med 1986;104:314.
26. Edwards JCW, Cambridge G. Is rheumatoid arthritis a failure of B cell death in synovium? Ann Rheum Dis 1995;54:696-700.
27. Marlor CW, Webb DL, Bombara MP, Greve JM, Blue ML. Expression of vascular cell adhesion molecular 1 in fibroblast-like synoviocytes after stimulation with TNF. Am J Pathol 1992;140:1055-60.
28. Morales Ducret J, Wayner E, Elices MJ et al. α4/β1 integrin (VLA-4) ligands in arthritis: Vascular cell adhesion molecule expression in synovium and on fibroblast-like synoviocytes. Arthritis Rheum 1992;49: 1424-31.
29. Winchester RJ, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Clin Exp Immunol 1970;6:689-706.
30. Willems GM, Janssen MP, Pelsers MM, Comfurius P, Galli M, Zwaal RF et al. Role of divalency in the high-affinity binding of anti-cardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry 1996;35:13833-42.
31. Stastny P. Association of the B-cell alloantigen DRw4 with RA. N Engl J Med 1978;298:869-71.
32. Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory synovitis. Scand J Rheumatol 1988; 76(suppl.):203-10.
33. Breedveld FC, Verweij CL. T cells in rheumatoid arthritis. Br J Rheumatol 1997;6:617-8.
34. Dolhain RJEM, van der Heiden AN, Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a Th1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;12:1961-9.
35. Pulendran B, van Driel R, Nossal GJV. Immunological tolerance in germinal centres. Immunol Today 1997; 18:27-32.
36. Reff ME, Carner K, Chambers KS et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994;83:435-45.
37. Maloney DG, Lues TM, Czerwinski DK et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994;84:2457-66.
38. Wicks I, Cooley H, Szer J. Autologous haemopoietic stem cell transplantation: a possible cure for rheumatoid arthritis. Arthritis Rheum 1997;6:1005-11.
39. Bhatia A, Blades S, Cambridge G, Edwards JCW. Differential distribution of FcyRIIIa in normal human tissues and colocalisation with DAF and fibrillin-1. Immunology 1998, in press.